Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Qtrypta (M207)

Qtrypta (M207)

Qtrypta (M207) is a proprietary formulation of zolmitriptan used for the acute treatment of migraine

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 May, 2022
sss sss profile picture
sss sss
edited on 21 May, 2022
Edits made to:
Topic thumbnail

Qtrypta (M207)

Qtrypta (M207) is a proprietary formulation of zolmitriptan used for the acute treatment of migraine

Edits on 20 Feb, 2022
N Ni profile picture
N Ni
edited on 20 Feb, 2022
Edits made to:
Infobox (+2 properties)
Description (+100 characters)
Topic thumbnail

Qtrypta (M207)

Qtrypta (M207) is a proprietary formulation of zolmitriptan used for the acute treatment of migraine

Infobox
Industry
Product parent company
Zosano Pharma
Zosano Pharma
"Created via: Web app"
N Ni profile picture
N Ni
created this topic on 20 Feb, 2022
Edits made to:
Infobox (+2 properties)
Topic thumbnail

 Qtrypta (M207)

Qtrypta (M207) is a proprietary formulation of zolmitriptan used for the acute treatment of migraine

Infobox
Is a
Product
Product
Website
https://www.zosanopharma.com/

Find more entities like Qtrypta (M207)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo